Research

Hormonal

Semaglutide 2.4 mg administered once weekly for 6 months produces a mean body weight reduction of 10.5 kg (10.0%) in adults with obesity or overweight, with 79% of patients achieving clinically significant weight loss (≥5%).

If you have obesity or overweight with a related health condition, semaglutide 2.4 mg taken once weekly can help you lose an average of 10% of your body weight over 6 months. This is significantly more effective than diet and exercise alone for many people. You should discuss with your doctor if this treatment is appropriate for you, especially if you haven't used other weight-loss medications before.

ModerateSupportsMEDIUM confidence
After 6 months, mean body weight change was −10.5 ± 6.8 kg ... and mean percentage body weight change was −10.0% ± 6.6% ... Most (79.0%) patients had ≥5% body weight reduction
Aleksandrina Ruseva et al. · Obesity Science & Practice · 2024

Why this rating

The study is a retrospective observational cohort study using real-world claims data, which establishes association but not causation and lacks a control group.

Source

Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real‐world setting: A 6‐month retrospective study in the United States (SCOPE)

Aleksandrina Ruseva et al. · Obesity Science & Practice · 2024

DOI 10.1002/osp4.737

cohort · n=343Cited 35×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →